Stride Arcolab Sept qtr PAT seen up 87% at Rs 30.5 cr
Dolat Capital has come out with its earning estimates on Pharma sector for the quarter ended September 2011. According to the research firm, Stride Arcolab September quarter net sales are expected to go up by 27.1% at Rs 547 crore, year-on-year, (YoY) basis.